Between 2:26 PM and 3:48 PM ET on September 11, I hit the order button four times. The first three were planned. The fourth was a correction.

The result: NOK’s PMCC went from 6 lots to 10. But what this review is really about is something else: one of those tickets went out in the wrong direction, and I’m not worried. Here’s why.

1. The Ledger First

📒 Ledger detail (click to expand)

Time (ET)	Contract	Side	Qty	Price	Cash flow
14:26	NOK SEP 18 ‘26 11P	Buy to close	2	$0.31	-$62
15:36	NOK JUN 17 ‘27 10C	Buy (LEAP)	4	$2.88	-$1,152
15:40	NOK SEP 25 ‘26 10.5P	Sell ← wrong direction	4	$0.22	+$88
15:48	NOK SEP 25 ‘26 12C	Sell ✅	4	$0.18	+$72
				Total	-$1,054

One more cleaned up on the side: 2x RGTI 15P (expiring 9/11), bought back at $0.05, realized +$27.33.

The point of that close isn’t the amount — it’s cutting off the “could take delivery at expiry” tail. At $0.05 the cost was essentially free, and it bought a clean weekend.

Account before and after:

Metric	Before	After
Net liquidation (NLV)	$8,841.84	$8,805.66
Cash	-$728.33	-$1,727.29
Leverage	1.360x	1.512x
Maintenance margin / NLV	50.9%	61.4%

2. Trade One: Buying Back the 11P at $0.31 to Lock +$265

Let me start with the comfortable one.

In mid-July I sold 2x NOK 11P (expiring 9/18) at $1.65. NOK was $9.97 then, so the 11 strike was deep in the money — that premium looked like the market handing out free money.

Then NOK rallied to $11.05. The put flipped from deep ITM to OTM and the premium decayed from $1.65 all the way to $0.31.

With 7 days left, I bought it back:

Sold at $1.65 → bought back at $0.31, 2 contracts × 100 shares = +$265.02 realized

Why not let it expire and keep everything? Because that put spent most of its life in the money, and any dip back under $10.99 within those 7 days meant owing $2,200 for delivery. Buying back at $0.31 pays 19% of the original premium to buy out the last week of uncertainty.

That is not cost-cutting. It’s buying insurance — and the premium was a rounding error.

3. Scaling the PMCC from 6 to 10 Lots

Trade two is the headline: buying 4x NOK 10C JUN 17 ‘27 (LEAP) at $2.88.

Why NOK rather than something else?

• It’s the only position in my account tagged tier = stable — not quantum, not blockchain, but a real company making communications equipment
• Liquidity is a hard metric: 85.9 million shares a day (68.3M over the last 10), and on the option side the LEAP carries 22,601 open interest with the 12C at 7,785. Compared with something like TRON — where you can’t get out when you want to — NOK has no exit problem at all
• Technicals: above the 20/50/200-day, RSI 63, MACD bullish above zero, +6.5% over 5 days
• Valuation: analyst target $14.96 (spot $11.05, +35% upside), rated buy; forward P/E around 22, earnings 10/22 (well clear of the 9/25 short-leg expiry)

The cost basis improved too. The original 6 LEAPs averaged $3.610; the new 4 came in at $2.88:

	Qty	Unit price	Amount
Existing	6	$3.610	$2,166
New	4	$2.88	$1,152
Blended	10	$3.3215	$3,321.55

Trade four completed the cover: selling 4x 12C SEP 25 at $0.18 for $72. Blended short-call cost ticked down from $0.182 to $0.1785.

One check is mandatory here — the coverage test. Whenever you see “LEAP + short call,” compute the stock-equivalent first:

Stock 0/100 = 0, plus 10 LEAPs = 10. Short calls = 10. 10 ≥ 10 → fully covered, no naked calls

Do not skip this. A reader once asked whether selling 10 calls meant I was naked short. The answer is in the formula: shares ÷ 100 + LEAPs ≥ short calls.

4. The Ticket I Sold in the Wrong Direction

Now the 15:40 fill.

My intent was to cover the 4 new LEAPs with short calls. Instead I sold 4x 10.5P thinking it was the 12C — I sold a put, not a call.

Eight minutes later, at 15:48, I entered the correct 12C.

The reason is mundane: puts and calls share the same strike ladder, 10.5 and 12 are adjacent numbers, and my hands moved faster than my eyes. But speed isn’t an excuse. Three things I actually got wrong:

1. I didn’t verify which Greek direction the trade represented before submitting. Selling a call collects theta; selling a put also collects theta. On the surface both are rent collection — but the obligations are opposite. A short call means “deliver shares if it rallies.” A short put means “pay cash if it drops.”
2. Two orders within four minutes is dangerous. Buy the LEAP at 15:36, sell the short leg at 15:40. Chasing price on both sides compressed my execution into a rhythm with no room for self-checking.
3. I did get one thing right: I corrected immediately. The bad ticket lived 8 minutes and cost roughly $8.

But even after the correction, those 4 puts are still on the books. The next section explains why I’m not worried.

5. Why a Wrong-Direction Fill Isn’t Fatal Here

This is the core idea of this review.

How dangerous a wrong-direction fill is depends entirely on the underlying — not on the mistake itself.

Picture the same mis-click landing on different names:

If I had sold the wrong side on	Assignment obligation	Consequence
TRON	400 × $5 = $2,000	Liquidity trap, can’t exit, concentration explodes
QUBT / RGTI	400 × $10 = $4,000	Small-cap quantum, high vol, no earnings — the deeper you go the worse
NOK (what happened)	400 × $10.50 = $4,200	Buying a large-cap I’m already long-term bullish on, at a discount

The same “sold a put instead of a call” is an incident on TRON and merely an early execution of a CSP I should have done anyway on NOK.

Three things support that:

1. The assignment price is itself a discount. $10.50 against a $11.05 spot is a 5% discount — and my long-term view on NOK is higher (target $14.96). The core creed of CSP is that assignment is a feature, not a bug: if it drops, you take delivery at the agreed price.

2. The capacity to absorb it is real. I still have capital not yet injected into the brokerage account this month. The $4,200 obligation = 400 shares × $10.50, covered by this month’s pending transfer plus the regular $780 monthly injection. This isn’t “I hope the market doesn’t assign me” — it’s “if it assigns me, I can pay.”

3. There’s a defined next step after assignment — continue the Wheel. If 400 shares land, the standard move is to immediately sell 4 Covered Calls against them (today’s 12C at $0.18 would be $72 per 13 days). Assign → sell CCs → collect rent → get called away for a gain. That’s the full Wheel loop, not a position stuck halfway.

The one number to be honest about: if NOK breaks below $10.50 for full assignment before 9/25, NOK exposure goes from 35.5% today to roughly 82.7%. Here is my handling list:

• Account level: absorb it with the pending injection; open nothing new
• Structure level: immediately sell 4 CCs against the shares, turning stock back into a rent-producing asset
• Time level: 13 days to 9/25, and Δ = -0.295 implies roughly a 70% chance it expires worthless

So my plan is “watch and choose the moment” — not a panicked buyback: close or roll when the price is right; if neither is attractive, let it run to expiry and take delivery if it comes to that.

6. Capacity and Leverage: How My Own Rules Read This

Let me be precise. This operation pushed leverage from 1.36x to 1.512x, cash from -$728 to -$1,727, and maintenance margin usage from 50.9% to 61.4%.

Against the leverage tiers I set for myself:

Band	Classification	Action
≤ 1.5x	long-term target	normal operation
1.5 – 1.8x	acceptable short-term, requires close monitoring	← currently 1.512x
> 2.0x	absolute hard stop	forbidden

1.512x sits in the “close monitoring” band, not over the line. Two constraints come with that, and I’m following both:

1. My next recommendation should favor deleveraging over a new position
2. New capital goes to rebuilding cash first, not to more positions

But there’s something I have to write down, because it’s a genuine gap in my rules:

My risk engine automatically flags RED / REDUCE_ONLY whenever cash is negative — but its model has no variable for “capital pending injection.”

So a mismatch appears: the system sees “cash -$1,727, no new positions,” while I see “another transfer is coming before month-end, so capacity exists.” Until the money actually lands, I choose to honor the system’s red flag — which is why “close the 4 puts at an opportune moment” is item one on my to-do list. But the rule itself needs fixing: either count committed injections as available capacity, or state unambiguously that pending capital cannot be used to open positions. A fuzzy zone is where discipline leaks.

7. Structure Check

All three legs together (pulled live after the close):

Leg	Qty	Mark	Δ	IV	DTE	OI
LEAP 10C JUN’27	+10	$2.86	0.695	59.2%	278	22,601
short 12C SEP’25	-10	$0.17	0.252	56.8%	13	7,785
short 10.5P SEP’25	-4	$0.23	-0.295	55.7%	13	431

Aggregate Greeks:

Metric	Value	Reading
Net Delta	+5.61	561 share-equivalent = $6,199 notional = 70.4% of NLV
Net Theta	+$16.64/day	Time is on my side
Net Vega	+$23.6 per 1% IV	I’m long volatility

Positive net theta is the most comfortable feature: the 10 LEAPs bleed $4.20/day, the 10 short calls bring in $15.00/day, the 4 short puts bring in $5.84/day — net +$16.64/day.

Two numbers to remember:

• LEAP break-even = $3.3215 + $10 = $13.32 against a $11.05 spot — NOK needs +20.5% to break even (before short-call income). A PMCC isn’t a guaranteed win; it has an explicit hurdle price.
• Net delta of 561 shares = 70.4% of NLV. NOK up 1% moves account equity about 0.7% — and the reverse holds. Concentration risk does not shrink because I like the company. It only shrinks when the position shrinks. This is the number I watch while staying calm.

8. Three Takeaways

1. The ceiling on your errors is set by the quality of the underlying, not by the error. The same “sold a put instead of a call” slip is an incident on TRON and just an early CSP on NOK. Choosing quality, then, is really buying insurance against every future slip you can’t foresee — you can’t control never making a mistake, but you can control what a mistake costs.

2. “I’m willing to take assignment” must come with a sentence about where the money comes from. I can say assignment doesn’t scare me not because I’m brave, but because the math is done: 400 shares × $10.50 = $4,200, covered by this month’s pending transfer plus the $780 monthly injection, and 4 CCs go on the moment the shares land. “I’m not scared” with no funding source is a slogan. With a funding source it’s a plan.

3. Rules have gaps; close them with rules, not with feelings. My engine doesn’t know about pending injections, so it flags RED when cash goes negative while I judge capacity as sufficient. The most dangerous property of that mismatch is that it can be argued away indefinitely as a “special case.” My handling this time: honor the red flag until the money lands, then write the variable into the rules properly instead of re-judging it every time.

A hunter isn’t afraid of getting hurt; he’s afraid of getting hurt while standing at the edge of a cliff. What actually needs managing was never “do I dare take this shot” — it’s “where is the way back after I do.” This time the way back was calculated, not imagined.

---

Current state: NOK = LEAP 10C (6/17/27) ×10 + short 12C (9/25) ×10 + short 10.5P (9/25) ×4. Coverage test: fully covered (10 ≥ 10), no naked calls. Account leverage 1.512x (close-monitoring band), cash -$1,727, margin usage 61.4%.

Open items:

1. 4x NOK 10.5P (9/25, Δ -0.295) — watch and pick the moment to close or roll; if assigned, absorb with the pending injection and immediately sell 4 CCs to continue the Wheel. Written decision by 9/23 at the latest
2. QUBT 8P (9/18, DTE 6, Δ -0.48 at the money) — assignment needs $1,600; this is not a name I want to own, so it must be handled before expiry
3. 10x NOK 12C (9/25, DTE 13) — check assignment probability inside the 3-day window; decide roll or let expire
4. New capital goes to rebuilding cash first; no new positions until leverage is back under 1.5x